Diabetic Nephropathies

"Diabetic Nephropathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Descriptor ID	D003928
MeSH Number(s)	C12.777.419.192 C13.351.968.419.192 C19.246.099.875
Concept/Terms	Diabetic Nephropathies Diabetic Nephropathies Nephropathies, Diabetic Nephropathy, Diabetic Diabetic Nephropathy Diabetic Kidney Disease Diabetic Kidney Diseases Kidney Disease, Diabetic Kidney Diseases, Diabetic Diabetic Glomerulosclerosis Diabetic Glomerulosclerosis Kimmelstiel-Wilson Syndrome Kimmelstiel Wilson Syndrome Syndrome, Kimmelstiel-Wilson Kimmelstiel-Wilson Disease Kimmelstiel Wilson Disease Nodular Glomerulosclerosis Glomerulosclerosis, Nodular Glomerulosclerosis, Diabetic Intracapillary Glomerulosclerosis

Below are MeSH descriptors whose meaning is more general than "Diabetic Nephropathies".

Diseases [C]
Male Urogenital Diseases [C12]
Urologic Diseases [C12.777]
Kidney Diseases [C12.777.419]
Diabetic Nephropathies [C12.777.419.192]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urologic Diseases [C13.351.968]
Kidney Diseases [C13.351.968.419]
Diabetic Nephropathies [C13.351.968.419.192]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Complications [C19.246.099]
Diabetic Nephropathies [C19.246.099.875]

Below are MeSH descriptors whose meaning is more specific than "Diabetic Nephropathies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetic Nephropathies" by people in this website by year, and whether "Diabetic Nephropathies" was a major or minor topic of these publications.

Bar chart showing 53 publications over 22 distinct years, with a maximum of 4 publications in 2004 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2001	3	0	3
2002	2	1	3
2003	0	3	3
2004	2	2	4
2005	1	0	1
2006	2	1	3
2008	3	0	3
2009	1	2	3
2010	1	0	1
2011	3	0	3
2012	2	0	2
2013	1	0	1
2014	2	0	2
2015	1	1	2
2017	1	1	2
2018	2	0	2
2019	2	1	3
2021	3	0	3
2022	2	0	2
2023	2	0	2
2024	4	0	4

Below are the most recent publications written about "Diabetic Nephropathies" by people in Profiles.

Lee HJ, Min L, Gao J, Matta S, Drel V, Saliba A, Tamayo I, Montellano R, Hejazi L, Maity S, Xu G, Grajeda BI, Roy S, Hallows KR, Choudhury GG, Kasinath BS, Sharma K. Female Protection Against Diabetic Kidney Disease Is Regulated by Kidney-Specific AMPK Activity. Diabetes. 2024 Jul 01; 73(7):1167-1177.

View in: PubMed
Darshi M, Kugathasan L, Maity S, Sridhar VS, Fernandez R, Limonte CP, Grajeda BI, Saliba A, Zhang G, Drel VR, Kim JJ, Montellano R, Tumova J, Montemayor D, Wang Z, Liu JJ, Wang J, Perkins BA, Lytvyn Y, Natarajan L, Lim SC, Feldman H, Toto R, Sedor JR, Patel J, Waikar SS, Brown J, Osman Y, He J, Chen J, Reeves WB, de Boer IH, Roy S, Vallon V, Hallan S, Gelfond JA, Cherney DZ, Sharma K. Glycolytic lactate in diabetic kidney disease. JCI Insight. 2024 Jun 10; 9(11).

View in: PubMed
Feng Y, Sun Z, Fu J, Zhong F, Zhang W, Wei C, Chen A, Liu BC, He JC, Lee K. Podocyte-derived soluble RARRES1 drives kidney disease progression through direct podocyte and proximal tubular injury. Kidney Int. 2024 Jul; 106(1):50-66.

View in: PubMed
Baldelomar EJ, Morozov D, Wilson LD, Eldeniz C, An H, Charlton JR, Bauer AQ, Keilholz SD, Hulbert ML, Bennett KM. Resting-state MRI reveals spontaneous physiological fluctuations in the kidney and tracks diabetic nephropathy in rats. Am J Physiol Renal Physiol. 2024 Jul 01; 327(1):F113-F127.

View in: PubMed
Norris KC, Williams SF, Nee R. Flattening the Playing Field for Treatment of Diabetic Kidney Disease. Semin Nephrol. 2023 05; 43(3):151428.

View in: PubMed
Sun L, Wu Y, Sinha SK, Nicholas SB, Zou LX. Performance of multi-biomarker panels based on urinary N-terminal osteopontin for prediction of diabetic kidney disease in patients with diabetes mellitus. Eur J Intern Med. 2023 12; 118:140-142.

View in: PubMed
Tuttle KR, Jones CR, Daratha KB, Koyama AK, Nicholas SB, Alicic RZ, Duru OK, Neumiller JJ, Norris KC, R?os Burrows N, Pavkov ME. Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020. N Engl J Med. 2022 10 13; 387(15):1430-1431.

View in: PubMed
Abegaz TM, Diaby V, Sherbeny F, Ali AA. Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA. Clin Drug Investig. 2022 Jun; 42(6):501-511.

View in: PubMed
Wang B, Qian JY, Tang TT, Lin LL, Yu N, Guo HL, Ni WJ, Lv LL, Wen Y, Li ZL, Wu M, Cao JY, Liu BC. VDR/Atg3 Axis Regulates Slit Diaphragm to Tight Junction Transition via p62-Mediated Autophagy Pathway in Diabetic Nephropathy. Diabetes. 2021 11; 70(11):2639-2651.

View in: PubMed
Cao A, Li J, Asadi M, Basgen JM, Zhu B, Yi Z, Jiang S, Doke T, El Shamy O, Patel N, Cravedi P, Azeloglu EU, Campbell KN, Menon M, Coca S, Zhang W, Wang H, Zen K, Liu Z, Murphy B, He JC, D'Agati VD, Susztak K, Kaufman L. DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity. J Clin Invest. 2021 05 17; 131(10).

View in: PubMed

People

Explore

Similar Concepts

Top Journals